Share This Author
Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain
- K. Michaelis, M. Hoffmann, K. Langer
- Biology, ChemistryJournal of Pharmacology and Experimental…
- 1 June 2006
Results indicate that apolipoprotein E attached to the surface of nanoparticles facilitates transport of drugs across the blood-brain barrier, probably after interaction with lipoprotein receptors on the brain capillary endothelial cell membranes.
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
The majority of eGFR-related loci are either associated or show a strong trend towards association with incident CKD, but have modest associations with ESRD in individuals of European descent.
Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
CONTEXT Paraganglioma syndrome includes inherited head and neck paragangliomas (HNPs) and adrenal or extra-adrenal pheochromocytomas and are classified according to the susceptibility genes SDHB,…
CYP2C19 Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- J. Weiss, Magdalena Maria Hoevel, G. Mikus
- Biology, MedicineJournal of clinical pharmacology
- 1 February 2009
Multiple regression analysis of voriconazole apparent oral clearance revealed that 49% of its variance can be explained solely by the CYP2C19 polymorphism (P < .0001).
SIRT3 deficiency impairs mitochondrial and contractile function in the heart
Lack of SIRT3 impairs mitochondrial and contractile function in the heart, likely due to increased acetylation of various energy metabolic proteins and subsequent myocardial energy depletion.
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out.
Evidence is given that clinical parameters can predict for mutation and help prioritize gene testing to reduce costs in HNP, and such strategy is cost-saving in the practice of genetics-based personalized health care.
The interleukin-6 G(–174)C promoter polymorphism in the LURIC cohort: no association with plasma interleukin-6, coronary artery disease, and myocardial infarction
- M. Nauck, B. Winkelmann, M. Hoffmann, B. Böhm, H. Wieland, W. März
- Biology, MedicineJournal of Molecular Medicine
- 21 June 2002
It is concluded that the IL-6 G(–174)C polymorphism is not associated with the risk of CAD or MI and does not contribute to cardiovascular risk stratification.
PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry
Larger association studies, identification of single-nucleotide polymorphisms with larger effects, or randomized trials of specific Lp-PLA2 inhibitors are needed to confirm or refute a contributory role for Lp -PLA2 in CHD.